FDA Backs Pfizer COVID-19 Boosters For Seniors, High-Risk

FILE - In this Sept. 14, 2021, file photo, a syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa. An influential panel of advisers to the Centers for Disease Control and Prevention met on Wednesday, Sept. 22, to decide who should get COVID-19 booster shots and when. (AP Photo/Matt Rourke)

The U.S. has moved a step closer to offering booster doses of Pfizer’s COVID-19 vaccine to seniors and others at high risk from the virus. The Food and Drug Administration on Wednesday signed off on such shots as a way to shore up protection in people with underlying health conditions and high-risk jobs. This is not a done deal yet: The Centers for Disease Control and Prevention has yet to weigh in on who it believes should get boosters and when. A panel of advisers to the agency will make more specific recommendations about who should get the extra shots and when.


Fred Cruz

Many Migrants Staying In US Even As Expulsion Flights Rise

Previous article

Abbott Signs Anti-Human Smuggling Bill Into Law

Next article

You may also like